Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements.

Durrieu-Gaillard S, Dumay-Odelot H, Boldina G, Tourasse NJ, Allard D, André F, Macari F, Choquet A, Lagarde P, Drutel G, Leste-Lasserre T, Petitet M, Lesluyes T, Lartigue-Faustin L, Dupuy JW, Chibon F, Roeder RG, Joubert D, Vagner S, Teichmann M.

Cell Cycle. 2018;17(5):605-615. doi: 10.1080/15384101.2017.1405881. Epub 2018 Jan 22.

PMID:
29171785
2.

[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].

Blais E, Pichon B, Mampuya A, Antoine M, Lagarde P, Kantor G, Breton-Callu C, Lefebvre C, Gerard M, Aamarcha A, Ozsahin M, Bourhis J, Maingon P, Troussier I, Pourel N.

Cancer Radiother. 2017 Oct;21(6-7):584-596. doi: 10.1016/j.canrad.2017.07.046. Epub 2017 Sep 5. Review. French.

PMID:
28886981
3.

Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.

Delespaul L, Lesluyes T, Pérot G, Brulard C, Lartigue L, Baud J, Lagarde P, Le Guellec S, Neuville A, Terrier P, Vince-Ranchère D, Schmidt S, Debant A, Coindre JM, Chibon F.

Clin Cancer Res. 2017 Feb 1;23(3):857-867. doi: 10.1158/1078-0432.CCR-16-0290. Epub 2016 Aug 15.

4.

[Practice evolution of hypofractionation in breast radiation therapy and medical impact].

Dupin C, Vilotte F, Lagarde P, Petit A, Breton-Callu C.

Cancer Radiother. 2016 Jun;20(4):299-303. doi: 10.1016/j.canrad.2016.04.005. Epub 2016 Jun 23. French.

PMID:
27344536
5.

Surface and Epitaxial Stresses on Supported Metal Clusters.

Lazzari R, Goniakowski J, Cabailh G, Cavallotti R, Trcera N, Lagarde P, Jupille J.

Nano Lett. 2016 Apr 13;16(4):2574-9. doi: 10.1021/acs.nanolett.6b00143. Epub 2016 Mar 7.

PMID:
26943368
6.

The LUCIA beamline at SOLEIL.

Vantelon D, Trcera N, Roy D, Moreno T, Mailly D, Guilet S, Metchalkov E, Delmotte F, Lassalle B, Lagarde P, Flank AM.

J Synchrotron Radiat. 2016 Mar;23(2):635-40. doi: 10.1107/S1600577516000746. Epub 2016 Feb 13.

PMID:
26917154
7.

RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.

Lesluyes T, Pérot G, Largeau MR, Brulard C, Lagarde P, Dapremont V, Lucchesi C, Neuville A, Terrier P, Vince-Ranchère D, Mendez-Lago M, Gut M, Gut I, Coindre JM, Chibon F.

Eur J Cancer. 2016 Apr;57:104-11. doi: 10.1016/j.ejca.2015.12.027. Epub 2016 Feb 23.

PMID:
26916546
8.

Study by EXAFS of the local structure around Si on silicene deposited on Ag(1 1 0) and Ag(1 1 1) surfaces.

Lagarde P, Chorro M, Roy D, Trcera N.

J Phys Condens Matter. 2016 Feb 24;28(7):075002. doi: 10.1088/0953-8984/28/7/075002. Epub 2016 Jan 26.

PMID:
26812888
9.

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G; ANRS 129 BKVIR Trial Group.

J Antimicrob Chemother. 2016 Mar;71(3):783-93. doi: 10.1093/jac/dkv384. Epub 2015 Dec 17.

PMID:
26679250
10.

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53.

Grellety T, Laroche-Clary A, Chaire V, Lagarde P, Chibon F, Neuville A, Italiano A.

BMC Cancer. 2015 Oct 13;15:684. doi: 10.1186/s12885-015-1667-1.

11.

Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin.

Laroche A, Tran-Cong K, Chaire V, Lagarde P, Hostein I, Coindre JM, Chibon F, Neuville A, Lesluyes T, Lucchesi C, Italiano A.

PLoS One. 2015 Oct 1;10(10):e0137794. doi: 10.1371/journal.pone.0137794. eCollection 2015.

12.

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7.

13.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

14.

Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.

de Figueiredo BH, Antoine M, Trouette R, Lagarde P, Petit A, Lamare F, Hatt M, Fernandez P.

Radiat Oncol. 2014 Dec 23;9:300. doi: 10.1186/s13014-014-0300-9.

15.

Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.

Lartigue L, Neuville A, Lagarde P, Brulard C, Rutkowski P, Dei Tos P, Wardelmann E, Debiec-Rychter M, Italiano A, Coindre JM, Chibon F.

Eur J Cancer. 2015 Jan;51(1):75-83. doi: 10.1016/j.ejca.2014.10.014. Epub 2014 Nov 6.

PMID:
25466504
16.

Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers.

Palussiere J, Lagarde P, Aupérin A, Deschamps F, Chomy F, de Baere T.

Cardiovasc Intervent Radiol. 2015 Feb;38(1):160-6. doi: 10.1007/s00270-014-0999-6. Epub 2014 Nov 14.

PMID:
25394595
17.

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

Chakiba C, Lagarde P, Pissaloux D, Neuville A, Brulard C, Pérot G, Coindre JM, Terrier P, Ranchere-Vince D, Ferrari A, Collini P, Suurmeijer AJ, Blay JY, Terrisse SA, Piperno-Neumann S, Averous G, Bui B, Orbach D, Italiano A, Chibon F.

Ann Oncol. 2014 Nov;25(11):2267-71. doi: 10.1093/annonc/mdu362. Epub 2014 Jul 28.

18.

Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas.

Skubitz KM, Skubitz AP, Xu WW, Luo X, Lagarde P, Coindre JM, Chibon F.

J Transl Med. 2014 Jun 20;12:176. doi: 10.1186/1479-5876-12-176.

19.

Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).

Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, Sagaon-Teyssier L, Lert F, Carrieri MP, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

AIDS Care. 2014;26 Suppl 1:S29-40. doi: 10.1080/09540121.2014.906553. Epub 2014 Apr 14.

PMID:
24731158
20.

[Postoperative radiation therapy for a patient with osteogenesis imperfecta: case report].

Ducournau A, Lagarde P, Henriques de Figueiredo B, Antoine M, Breton-Callu C, Petit A, Dallaudière B, Sargos P.

Cancer Radiother. 2014 Mar;18(2):132-5. doi: 10.1016/j.canrad.2013.09.008. Epub 2014 Mar 11. French.

PMID:
24629322

Supplemental Content

Loading ...
Support Center